Jamison Private Wealth Management
GSK icon

Jamison Private Wealth Management’s GSK GSK Stock Holding History

Jamison Private Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$871K Sell
18,083
-286
-2% -$14.6K 0.09% 125
2026
Q2 		$963K Sell
18,369
-162
-0.9% -$8.57K 0.1% 124
2026
Q1 		$1.02M Buy
18,531
+919
+5% +$49.8K 0.12% 117
2025
Q4 		$864K Sell
17,612
-293
-2% -$13.7K 0.1% 123
2025
Q3 		$773K Buy
17,905
+645
+4% +$25.2K 0.1% 128
2025
Q2 		$663K Sell
17,260
-227
-1% -$8.67K 0.1% 129
2025
Q1 		$677K Buy
17,487
+449
+3% +$16.4K 0.1% 120
2024
Q4 		$576K Sell
17,038
-811
-5% -$29.2K 0.09% 136
2024
Q3 		$730K Buy
17,849
+784
+5% +$32.1K 0.11% 116
2024
Q2 		$657K Buy
17,065
+1,292
+8% +$54.3K 0.11% 113
2024
Q1 		$676K Buy
15,773
+142
+0.9% +$5.86K 0.11% 119
2023
Q4 		$579K Sell
15,631
-408
-3% -$14.6K 0.11% 125
2023
Q3 		$581K Buy
+16,039
New +$569K 0.12% 113

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Equity Investment Corp
Equity Investment Corp Atlanta, Georgia $5.3B AUM 8.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Jamison Private Wealth Management's GSK Position: Q3 2026 in Review

Jamison Private Wealth Management reduced its GSK (GSK) stake by 1.6% in Q3 2026, selling an estimated $14.6K and leaving 18,083 shares worth $871K. The position accounts for 0.09% of the portfolio, ranked #125.

Jamison Private Wealth Management first reported a position in GSK in Q3 2023 and has held it in 13 quarters since. The position peaked at $1.02M in Q1 2026. 654 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Jamison Private Wealth Management held 18,083 shares of GSK worth $871K as of Q3 2026.
  • Jamison Private Wealth Management sold 286 GSK shares in Q3 2026, an estimated $14.6K.
  • GSK made up 0.09% of Jamison Private Wealth Management's portfolio in Q3 2026, its #125 holding.
  • Jamison Private Wealth Management first reported a position in GSK in Q3 2023 and has held it in 13 quarters since.
  • Jamison Private Wealth Management's GSK position peaked at $1.02M in Q1 2026.
  • 654 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Jamison Private Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.